Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q2 2024 Earnings Call Transcript August 9, 2024
Amneal Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.05263 EPS, expectations were $0.14.
Operator: Good morning and welcome to the Amneal Pharmaceuticals Second Quarter 2024 Earnings Call. I’d now like to turn the call over to Amneal’s Head of Investor Relations, Tony DiMeo.
Tony DiMeo: Good morning and thank you for joining Amneal Pharmaceuticals second quarter 2024 earnings...
